HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SCH 32615

Also Known As:

(N-(1-carboxy-2-phenyl)ethyl)phenylalanyl-B-alanine; SCH-32615; beta-Alanine, N-(N-(1-carboxy-2-phenylethyl)-L-phenylalanyl)-, (S)-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - Dipeptides: 945
      - SCH 32615: 2

Related Diseases

1.	Shock 04/17/1991 - "In the nucleus accumbens, dopamine metabolism was increased to the same extent by foot-shock and SCH 32615 administered separately, but these effects were not additive, suggesting that SCH 32615 and foot-shock act via a common mechanism. " 04/17/1991 - "The increase in DOPAC content in the prefrontal cortex elicited by foot-shock was unaffected by pretreatment with SCH 32615. "
2.	Catalepsy 06/01/1995 - "The administration of SCH 32615 (3 mg/kg) decreased both D-1 and D-2 antagonist-induced catalepsy. " 06/01/1995 - "To test this hypothesis, the effects of SCH 32615, an enkephalinase inhibitor, on DA antagonist-induced catalepsy, DA D-1 agonist-induced non-stereotyped grooming, and DA D-2 agonist-induced stereotyped behavior were studied. "

Related Drugs and Biologics

1.	Neprilysin (Neutral Endopeptidase)
2.	3,4-Dihydroxyphenylacetic Acid
3.	Dopamine (Intropin)